OFIX insider buying and SEC filings, explained

Orthofix Medical Inc. · CIK 884624

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Insider activity in the last 12 months

Bought

$6.8M

Insiders who bought

Sold (not marked 10b5-1)

$878K

Planned sales (10b5-1)

$3K

Insider purchases and sales, last 12 months

Traded	Type	What was filed	Source
Oct 1, 2026	Planned (10b5-1)	Patrick Fisher (President / COO) sold 150 shares at $9.44 ($1K), marked as a 10b5-1 plan trade. Holdings down <1% to 50,919 shares.	SEC filing Filed Oct 5, 2026, 4:20 PM ET
Sep 18–21, 2026	Purchase (code P) Amended filing	Alexis P. Michas (10% owner) bought 310,000 shares indirectly (by entity) between Sep 18 and Sep 21 at about $8.81 ($2.7M), reported as a purchase (code P). Holdings by entity up 9% to 3,771,216 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. This amends a filing from Sep 22.	SEC filing Filed Sep 23, 2026
Sep 1, 2026	Planned (10b5-1)	Patrick Fisher (President / COO) sold 150 shares at $9.39 ($1K), marked as a 10b5-1 plan trade. Holdings down <1% to 51,069 shares.	SEC filing Filed Sep 3, 2026
Aug 18, 2026	Sale	Patrick Fisher (President / COO) sold 1,295 shares at $10.09 ($13K). Holdings down 2% to 51,219 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Aug 20, 2026
Jun 18, 2026	Sale	Aviva McPherron (Pres, Global Ops & Qual) sold 3,670 shares at $9.38 ($34K). Holdings down 5% to 66,330 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Jun 22, 2026
May 7, 2026	Purchase (code P)	John B. Henneman III (Director) bought 5,000 shares at $12.26 ($61K), reported as a purchase (code P). Holdings up 6% to 90,809 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed May 8, 2026
May 5–7, 2026	Purchase (code P)	Arnaud Ajdler (10% owner) bought 184,896 shares indirectly (by entity) between May 5 and May 7 at about $12.08 ($2.2M), reported as a purchase (code P). Holdings by entity up 5% to 3,848,573 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 7 other reporting owners.	SEC filing Filed May 7, 2026
Apr 16, 2026	Sale	Jorge Andres Cedron (CLO) sold 3,743 shares at $12.82 ($48K). Holdings down 6% to 59,006 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Apr 20, 2026
Mar 17, 2026	Sale	Lucas Vitale (Cp&boo) sold 4,269 shares at $11.92 ($51K). Holdings down 3% to 160,449 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Mar 19, 2026
Mar 9–10, 2026	Purchase (code P)	Vickie L. Capps (Director) bought 5,000 shares between Mar 9 and Mar 10 at about $12.46 ($62K), reported as a purchase (code P). Holdings up 22% to 27,585 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Mar 10, 2026
Mar 4–5, 2026	Sale	Julie Andrews (CFO) sold 4,788 shares between Mar 4 and Mar 5 at about $12.74 ($61K). Holdings down 5% to 88,746 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Mar 6, 2026
Mar 4–5, 2026	Sale	Lucas Vitale (Cp&boo) sold 2,312 shares between Mar 4 and Mar 5 at about $12.74 ($29K). Holdings down 1% to 164,718 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Mar 6, 2026
Mar 4–5, 2026	Sale	Massimo Calafiore (CEO and Director) sold 12,220 shares between Mar 4 and Mar 5 at about $12.74 ($156K). Holdings down 4% to 320,136 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Mar 6, 2026
Mar 4–5, 2026	Sale	Patrick Fisher (President / COO) sold 1,536 shares between Mar 4 and Mar 5 at about $12.74 ($20K). Holdings down 3% to 50,633 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Mar 6, 2026
Mar 4–5, 2026	Sale	Aviva McPherron (Pres, Global Ops & Qual) sold 2,559 shares between Mar 4 and Mar 5 at about $12.74 ($33K). Holdings down 4% to 67,853 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Mar 6, 2026
Mar 4–5, 2026	Sale	Max Reinhardt (President / COO) sold 2,133 shares between Mar 4 and Mar 5 at about $12.74 ($27K). Holdings down 8% to 25,348 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Mar 6, 2026
Mar 4–5, 2026	Sale	Jorge Andres Cedron (CLO) sold 2,775 shares between Mar 4 and Mar 5 at about $12.74 ($35K). Holdings down 4% to 62,749 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Mar 6, 2026
Feb 24–25, 2026	Purchase (code P)	Arnaud Ajdler (10% owner) bought 137,858 shares indirectly (by entity) between Feb 24 and Feb 25 at about $12.59 ($1.7M), reported as a purchase (code P). Holdings by entity up 4% to 3,673,092 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 7 other reporting owners.	SEC filing Filed Feb 26, 2026
Jan 16, 2026	Sale	Julie Andrews (CFO) sold 4,873 shares at $14.38 ($70K). Holdings down 8% to 58,039 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Jan 21, 2026
Jan 9–12, 2026	Sale	Massimo Calafiore (CEO and Director) sold 19,397 shares between Jan 9 and Jan 12 at about $15.51 ($301K). Holdings down 8% to 217,237 shares. Not marked as a 10b5-1 plan trade.	SEC filing Filed Jan 13, 2026

18 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

2 insiders bought in 30 days

$2.3M in purchases since May 7, 2026 · Purchases traded May 7, 2026 to May 7, 2026 · Closed

Insider	Value	Traded	Source
Arnaud Ajdler (10% owner)	$2.2M	May 7, 2026	SEC filing
John B. Henneman III (Director)	$61K	May 7, 2026	SEC filing

2 insiders bought in 30 days

$1.8M in purchases since Feb 25, 2026 · Purchases traded Feb 25, 2026 to Mar 10, 2026 · Closed

Insider	Value	Traded	Source
Arnaud Ajdler (10% owner)	$1.7M	Feb 25, 2026	SEC filing
Vickie L. Capps (Director)	$62K	Mar 10, 2026	SEC filing

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow OFIX in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app